Sangamo Therapeutics Inc (SGMO) Stock Could Soon Reward Patient Investors

Sangamo Therapeutics Inc (NASDAQ: SGMO) is -54.41% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SGMO stock was last observed hovering at around $0.46 in the last trading session, with the day’s gains setting it 0.01%.

Currently trading at $0.47, the stock is -15.37% and -30.14% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.17 million and changing 1.59% at the moment leaves the stock -60.62% off its SMA200. SGMO registered -25.16% loss for a year compared to 6-month loss of -76.03%. The firm has a 50-day simple moving average (SMA 50) of $0.6662 and a 200-day simple moving average (SMA200) of $1.1813.

The stock witnessed a -39.77% gain in the last 1 month and extending the period to 3 months gives it a -54.41%, and is -5.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.73% over the week and 12.19% over the month.

Sangamo Therapeutics Inc (SGMO) has around 183 employees, a market worth around $114.11M and $63.76M in sales. Profit margin for the company is -126.63%. Distance from 52-week low is 52.96% and -85.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-271.09%).

The EPS is expected to grow by 25.07% this year.

Sangamo Therapeutics Inc (SGMO) Top Institutional Holders

153.0 institutions hold shares in Sangamo Therapeutics Inc (SGMO), with institutional investors hold 22.99% of the company’s shares. The shares outstanding are 245.40M, and float is at 234.35M with Short Float at 13.62%. Institutions hold 22.35% of the Float.

The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 9.8509% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 6.894 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 5.8341% and valued at over $4.26 million, while BLACKROCK INC. holds 2.306 of the shares totaling 4.7 million with a market value of $1.69 million.

Sangamo Therapeutics Inc (SGMO) Insider Activity

#####

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.